Insulin deficiency and reduced expression of lipogenic enzymes in cardiomyopathic hamster

A Vecchini1, L Binaglia, M Bibeau

  • 1Institute of Biochemistry, Faculty of Medicine, University of Perugia, 06126 Perugia, Italy.

Journal of Lipid Research
|February 13, 2001
PubMed

Insights

Cardiomyopathic hamsters exhibit widespread lipid metabolism disturbances, including reduced lipogenic enzyme activity and impaired gene expression. This metabolic defect is linked to low insulin levels in affected animals.

Area of Science:

  • Biochemistry
  • Cardiovascular Biology
  • Metabolic Research

Background:

  • The cardiomyopathic UM-X7.1 hamster model displays distinct lipid profiles in cardiac and non-cardiac tissues compared to healthy controls.
  • Preliminary observations suggest a generalized disturbance in lipid metabolism in cardiomyopathic hamsters.

Purpose of the Study:

  • To investigate hepatic lipid biosynthesis in cardiomyopathic versus healthy Syrian hamsters.
  • To identify the molecular mechanisms underlying lipid metabolism alterations in cardiomyopathy.

Main Methods:

  • Comparative analysis of hepatic lipid composition and enzyme activities (fatty acid synthase, stearoyl-CoA desaturase).
  • Northern blot analysis to assess mRNA levels of lipogenic enzymes and S14 nuclear protein.
  • Evaluation of dietary influences on gene expression in both hamster groups.

Main Results:

  • Cardiomyopathic hamsters showed significantly lower fatty acid synthase and stearoyl-CoA desaturase activities in the liver.
  • Impaired gene transcription for key lipogenic enzymes was observed in UM-X7.1 hamsters.
  • Dietary carbohydrates were less effective in inducing lipogenic enzyme expression in cardiomyopathic livers.

Conclusions:

  • The cardiomyopathic hamster model is characterized by a generalized disruption of lipid metabolism.
  • Reduced expression of lipogenic enzymes and impaired gene transcription are key features.
  • Low plasma insulin levels appear to be the primary determinant of the observed metabolic defect.